Arginase activity mediates retinal inflammation in endotoxin-induced uveitis

Wenbo Zhang, Babak Baban, Modesto Rojas, Sohrab Tofigh, Suvika K. Virmani, Chintan Patel, M. Ali Behzadian, Maritza J. Romero, Robert W. Caldwell, Ruth B. Caldwell

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Arginase has been reported to reduce nitric oxide bioavailability in cardiovascular disease. However, its specific role in retinopathy has not been studied. In this study, we assessed the role of arginase in a mouse model of endotoxin-induced uveitis induced by lipopolysaccharide (LPS) treatment. Measurement of arginase expression and activity in the retina revealed a significant increase in arginase activity that was associated with increases in both mRNA and protein levels of arginase (Arg)1 but not Arg2. Immunofluorescence and flow cytometry confirmed this increase in Arg1, which was localized to glia and microglia. Arg1 expression and activity were also increased in cultured Muller cells and microglia treated with LPS. To test whether arginase has a role in the development of retinal inflammation, experiments were performed in mice deficient in one copy of the Arg1 gene and both copies of the Arg2 gene or in mice treated with a selective arginase inhibitor. These studies showed that LPS-induced increases in inflammatory protein production, leukostasis, retinal damage, signs of anterior uveitis, and uncoupling of nitric oxide synthase were blocked by either knockdown or inhibition of arginase. Furthermore, the LPS-induced increase in Arg1 expression was abrogated by blocking NADPH oxidase. In conclusion, these studies suggest that LPS-induced retinal inflammation in endotoxin-induced uveitis is mediated by NADPH oxidase-dependent increases in arginase activity.

Original languageEnglish (US)
Pages (from-to)891-902
Number of pages12
JournalAmerican Journal of Pathology
Volume175
Issue number2
DOIs
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

Arginase
Uveitis
Endotoxins
Inflammation
Lipopolysaccharides
NADPH Oxidase
Microglia
Leukostasis
Ependymoglial Cells
Anterior Uveitis
Nitric Oxide Synthase
Neuroglia
Biological Availability
Genes
Fluorescent Antibody Technique
Retina
Cultured Cells
Flow Cytometry
Nitric Oxide
Proteins

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Zhang, W., Baban, B., Rojas, M., Tofigh, S., Virmani, S. K., Patel, C., ... Caldwell, R. B. (2009). Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. American Journal of Pathology, 175(2), 891-902. https://doi.org/10.2353/ajpath.2009.081115

Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. / Zhang, Wenbo; Baban, Babak; Rojas, Modesto; Tofigh, Sohrab; Virmani, Suvika K.; Patel, Chintan; Behzadian, M. Ali; Romero, Maritza J.; Caldwell, Robert W.; Caldwell, Ruth B.

In: American Journal of Pathology, Vol. 175, No. 2, 08.2009, p. 891-902.

Research output: Contribution to journalArticle

Zhang, W, Baban, B, Rojas, M, Tofigh, S, Virmani, SK, Patel, C, Behzadian, MA, Romero, MJ, Caldwell, RW & Caldwell, RB 2009, 'Arginase activity mediates retinal inflammation in endotoxin-induced uveitis', American Journal of Pathology, vol. 175, no. 2, pp. 891-902. https://doi.org/10.2353/ajpath.2009.081115
Zhang, Wenbo ; Baban, Babak ; Rojas, Modesto ; Tofigh, Sohrab ; Virmani, Suvika K. ; Patel, Chintan ; Behzadian, M. Ali ; Romero, Maritza J. ; Caldwell, Robert W. ; Caldwell, Ruth B. / Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. In: American Journal of Pathology. 2009 ; Vol. 175, No. 2. pp. 891-902.
@article{dd24eba3783747c5829bc306aa31c292,
title = "Arginase activity mediates retinal inflammation in endotoxin-induced uveitis",
abstract = "Arginase has been reported to reduce nitric oxide bioavailability in cardiovascular disease. However, its specific role in retinopathy has not been studied. In this study, we assessed the role of arginase in a mouse model of endotoxin-induced uveitis induced by lipopolysaccharide (LPS) treatment. Measurement of arginase expression and activity in the retina revealed a significant increase in arginase activity that was associated with increases in both mRNA and protein levels of arginase (Arg)1 but not Arg2. Immunofluorescence and flow cytometry confirmed this increase in Arg1, which was localized to glia and microglia. Arg1 expression and activity were also increased in cultured Muller cells and microglia treated with LPS. To test whether arginase has a role in the development of retinal inflammation, experiments were performed in mice deficient in one copy of the Arg1 gene and both copies of the Arg2 gene or in mice treated with a selective arginase inhibitor. These studies showed that LPS-induced increases in inflammatory protein production, leukostasis, retinal damage, signs of anterior uveitis, and uncoupling of nitric oxide synthase were blocked by either knockdown or inhibition of arginase. Furthermore, the LPS-induced increase in Arg1 expression was abrogated by blocking NADPH oxidase. In conclusion, these studies suggest that LPS-induced retinal inflammation in endotoxin-induced uveitis is mediated by NADPH oxidase-dependent increases in arginase activity.",
author = "Wenbo Zhang and Babak Baban and Modesto Rojas and Sohrab Tofigh and Virmani, {Suvika K.} and Chintan Patel and Behzadian, {M. Ali} and Romero, {Maritza J.} and Caldwell, {Robert W.} and Caldwell, {Ruth B.}",
year = "2009",
month = "8",
doi = "10.2353/ajpath.2009.081115",
language = "English (US)",
volume = "175",
pages = "891--902",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Arginase activity mediates retinal inflammation in endotoxin-induced uveitis

AU - Zhang, Wenbo

AU - Baban, Babak

AU - Rojas, Modesto

AU - Tofigh, Sohrab

AU - Virmani, Suvika K.

AU - Patel, Chintan

AU - Behzadian, M. Ali

AU - Romero, Maritza J.

AU - Caldwell, Robert W.

AU - Caldwell, Ruth B.

PY - 2009/8

Y1 - 2009/8

N2 - Arginase has been reported to reduce nitric oxide bioavailability in cardiovascular disease. However, its specific role in retinopathy has not been studied. In this study, we assessed the role of arginase in a mouse model of endotoxin-induced uveitis induced by lipopolysaccharide (LPS) treatment. Measurement of arginase expression and activity in the retina revealed a significant increase in arginase activity that was associated with increases in both mRNA and protein levels of arginase (Arg)1 but not Arg2. Immunofluorescence and flow cytometry confirmed this increase in Arg1, which was localized to glia and microglia. Arg1 expression and activity were also increased in cultured Muller cells and microglia treated with LPS. To test whether arginase has a role in the development of retinal inflammation, experiments were performed in mice deficient in one copy of the Arg1 gene and both copies of the Arg2 gene or in mice treated with a selective arginase inhibitor. These studies showed that LPS-induced increases in inflammatory protein production, leukostasis, retinal damage, signs of anterior uveitis, and uncoupling of nitric oxide synthase were blocked by either knockdown or inhibition of arginase. Furthermore, the LPS-induced increase in Arg1 expression was abrogated by blocking NADPH oxidase. In conclusion, these studies suggest that LPS-induced retinal inflammation in endotoxin-induced uveitis is mediated by NADPH oxidase-dependent increases in arginase activity.

AB - Arginase has been reported to reduce nitric oxide bioavailability in cardiovascular disease. However, its specific role in retinopathy has not been studied. In this study, we assessed the role of arginase in a mouse model of endotoxin-induced uveitis induced by lipopolysaccharide (LPS) treatment. Measurement of arginase expression and activity in the retina revealed a significant increase in arginase activity that was associated with increases in both mRNA and protein levels of arginase (Arg)1 but not Arg2. Immunofluorescence and flow cytometry confirmed this increase in Arg1, which was localized to glia and microglia. Arg1 expression and activity were also increased in cultured Muller cells and microglia treated with LPS. To test whether arginase has a role in the development of retinal inflammation, experiments were performed in mice deficient in one copy of the Arg1 gene and both copies of the Arg2 gene or in mice treated with a selective arginase inhibitor. These studies showed that LPS-induced increases in inflammatory protein production, leukostasis, retinal damage, signs of anterior uveitis, and uncoupling of nitric oxide synthase were blocked by either knockdown or inhibition of arginase. Furthermore, the LPS-induced increase in Arg1 expression was abrogated by blocking NADPH oxidase. In conclusion, these studies suggest that LPS-induced retinal inflammation in endotoxin-induced uveitis is mediated by NADPH oxidase-dependent increases in arginase activity.

UR - http://www.scopus.com/inward/record.url?scp=68449088413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68449088413&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2009.081115

DO - 10.2353/ajpath.2009.081115

M3 - Article

C2 - 19590038

AN - SCOPUS:68449088413

VL - 175

SP - 891

EP - 902

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -